Skip to content

Quality of life and burden of disease in patients with hypoparathyroidism after thyroid surgery in the Southwestern region of the Netherlands.

Quality of life and burden of disease in patients with hypoparathyroidism after thyroid surgery in the Southwestern region of the Netherlands. - Quality of life in patients with persistent postsurgical hypoparathyroidism

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON49191
Enrollment
225
Registered
2019-01-25
Start date
2019-03-19
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypoparathyroidism inadequate secretion of parathyroid hormone

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients who are aged 18 years or older at the time of inclusion - Patients who gave informed consent - Both cases and controls underwent (completion) thyroidectomy - Cases have persisting hypoparathyroidism according to the previously mentioned definition and controls do not

Exclusion criteria

Exclusion criteria: - Patients who are not able to provide written informed consent - No adequate understanding of the Dutch language - Parathyroid disease or parathyroid surgery

Design outcomes

Primary

MeasureTime frame
Main study endpoints are quality of life in patients with hypoparathyroidism as measured by the physical component score of the SF-36. Other endpoints are cognitive and functional outcomes and burden of disease (eg. extra visits, employment status, comorbidities).

Secondary

MeasureTime frame
The secondary objectives of this study are: - To determine the Thyroid-Related quality of life in patients with hypoparathyrodism - To determine the cognitive and functional outcomes in patients with hypoparathyrodism - To determine the burden of disease in patients with hypoparathyroidism (eg. Medication use, the absence of work/return to work, extra hospital visits, comorbidities, hypoparathyroidism related laboratory parameters)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)